Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye

IASLC Announces Results of 2023 Board of Directors Election

JTO Continues to Rank Among the Most-Cited Oncology Journals

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

In Case You Missed It: IASLC Launches New Education Center

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

In Case You Missed It: Recent News from IASLC

IASLC Names New Chief Science Officer

IASLC Calls For Documentation of Tobacco Use in Cancer Clinical Trials

In Brief for January 10, 2024

Abstract Submissions, Reviewer Workshop Applications Open for WCLC

Scientist, Advocate, and Leader: A Q&A with Dr. Jennifer King